Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 128

1.

Comment on 'metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter study'.

Lalau JD, Bennis Y, De Broe M.

Clin Toxicol (Phila). 2019 Dec 2:1. doi: 10.1080/15563650.2019.1678757. [Epub ahead of print] No abstract available.

PMID:
31790282
2.

Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.

Vantyghem MC, Chetboun M, Gmyr V, Jannin A, Espiard S, Le Mapihan K, Raverdy V, Delalleau N, Machuron F, Hubert T, Frimat M, Van Belle E, Hazzan M, Pigny P, Noel C, Caiazzo R, Kerr-Conte J, Pattou F; Members of the Spanish Back Pain Research Network Task Force for the Improvement of Inter-Disciplinary Management of Spinal Metastasis.

Diabetes Care. 2019 Nov;42(11):2042-2049. doi: 10.2337/dc19-0401.

PMID:
31615852
3.

Short-Term Assessment of Obstructive Sleep Apnea Syndrome Remission Rate after Sleeve Gastrectomy: a Cohort Study.

Timmerman M, Basille D, Basille-Fantinato A, Baud ME, Rebibo L, Andrejak C, Jounieaux V, Lalau JD.

Obes Surg. 2019 Nov;29(11):3690-3697. doi: 10.1007/s11695-019-04110-0.

PMID:
31346929
4.

Metformin as a protective agent against natural or chemical toxicities: a comprehensive review on drug repositioning.

Meshkani SE, Mahdian D, Abbaszadeh-Goudarzi K, Abroudi M, Dadashizadeh G, Lalau JD, De Broe ME, Hosseinzadeh H.

J Endocrinol Invest. 2020 Jan;43(1):1-19. doi: 10.1007/s40618-019-01060-3. Epub 2019 May 16. Review.

PMID:
31098946
5.

Perceptions of insulin therapy in people with type 2 diabetes and physicians: a cross-sectional survey conducted in France.

Cosson E, Mauchant C, Benabbad I, Le Pape G, Le Bleis M, Bailleul F, Lalau JD.

Patient Prefer Adherence. 2019 Feb 11;13:251-260. doi: 10.2147/PPA.S181363. eCollection 2019.

6.

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators.

Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2.

PMID:
30291013
7.

High burden of recurrent cardiovascular events in heterozygous familial hypercholesterolemia: The French Familial Hypercholesterolemia Registry.

Béliard S, Boccara F, Cariou B, Carrié A, Collet X, Farnier M, Ferrières J, Krempf M, Peretti N, Rabès JP, Varret M, Vimont A, Charrière S, Bruckert E; French FH Registry group.

Atherosclerosis. 2018 Oct;277:334-340. doi: 10.1016/j.atherosclerosis.2018.08.010.

PMID:
30270068
8.

Disordered eating behaviors as a potential obesogenic factor in schizophrenia.

Kouidrat Y, Amad A, Stubbs B, Louhou R, Renard N, Diouf M, Lalau JD, Loas G.

Psychiatry Res. 2018 Nov;269:450-454. doi: 10.1016/j.psychres.2018.08.083. Epub 2018 Aug 28.

PMID:
30195737
9.

Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.

Neven E, Vervaet B, Brand K, Gottwald-Hostalek U, Opdebeeck B, De Maré A, Verhulst A, Lalau JD, Kamel S, De Broe ME, D'Haese PC.

Kidney Int. 2018 Jul;94(1):102-113. doi: 10.1016/j.kint.2018.01.027. Epub 2018 Apr 30.

PMID:
29716795
10.

Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4.

Lalau JD, Kajbaf F, Bennis Y, Hurtel-Lemaire AS, Belpaire F, De Broe ME.

Diabetes Care. 2018 Mar;41(3):547-553. doi: 10.2337/dc17-2231. Epub 2018 Jan 5.

PMID:
29305402
11.

Renoprotective Effects of Metformin.

De Broe ME, Kajbaf F, Lalau JD.

Nephron. 2018;138(4):261-274. doi: 10.1159/000481951. Epub 2017 Dec 14. Review.

12.

Compliance with a multidisciplinary team meeting's decision prior to bariatric surgery protects against major postoperative complications.

Rebibo L, Maréchal V, De Lameth I, Dhahri A, Escoffier I, Lalau JD, Regimbeau JM.

Surg Obes Relat Dis. 2017 Sep;13(9):1537-1543. doi: 10.1016/j.soard.2017.05.026. Epub 2017 Jun 1.

PMID:
28705572
13.

Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm.

Lalau JD, Kajbaf F, Protti A, Christensen MM, De Broe ME, Wiernsperger N.

Diabetes Obes Metab. 2017 Nov;19(11):1502-1512. doi: 10.1111/dom.12974. Epub 2017 Jul 11. Review.

PMID:
28417525
14.

Equivalence Study of Two Temperature-Measurement Methods in Febrile Adult Patients With Cancer.

Mason TM, Boubekri A, Lalau J, Patterson A, Hartranft SR, Sutton SK.

Oncol Nurs Forum. 2017 Mar 1;44(2):E82-E87. doi: 10.1188/17.ONF.E82-E87.

PMID:
28222086
15.

Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.

Mary A, Hartemann A, Liabeuf S, Aubert CE, Kemel S, Salem JE, Cluzel P, Lenglet A, Massy ZA, Lalau JD, Mentaverri R, Bourron O, Kamel S.

Cardiovasc Diabetol. 2017 Feb 15;16(1):24. doi: 10.1186/s12933-017-0509-7.

16.

Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.

Kouidrat Y, Zaitouni A, Amad A, Diouf M, Desailloud R, Loas G, Lalau JD.

J Diabetes Complications. 2017 Jan;31(1):108-113. doi: 10.1016/j.jdiacomp.2016.10.026. Epub 2016 Oct 29.

PMID:
27847146
17.

The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients.

Béliard S, Millier A, Carreau V, Carrié A, Moulin P, Fredenrich A, Farnier M, Luc G, Rosenbaum D, Toumi M, Bruckert E; French FH Registry group.

J Clin Lipidol. 2016 Sep-Oct;10(5):1129-1136.e3. doi: 10.1016/j.jacl.2016.06.007. Epub 2016 Jun 27.

PMID:
27678429
18.

[Management of eating disorders in schizophrenia].

Kouidrat Y, Amad A, Renard N, Corneille F, Lalau JD, Loas G.

Soins Psychiatr. 2016 May-Jun;(304):39-43. doi: 10.1016/j.spsy.2015.04.011. Review. French.

PMID:
27157198
19.

Metformin Poisoning: A Debate on Recommendations for Extracorporeal Treatment.

Lalau JD, Kajbaf F.

Crit Care Med. 2015 Nov;43(11):e534. doi: 10.1097/CCM.0000000000001229. No abstract available.

PMID:
26468726
20.

Unexpectedly long half-life of metformin elimination in cases of metformin accumulation.

Kajbaf F, Bennis Y, Hurtel-Lemaire AS, Andréjak M, Lalau JD.

Diabet Med. 2016 Jan;33(1):105-10. doi: 10.1111/dme.12959. Epub 2015 Oct 16.

PMID:
26337524

Supplemental Content

Loading ...
Support Center